Pharmalot Ed Silverman STAT Plus: Pharmalittle: White House to tap cancer center chief to lead NIH; generic abortion pill maker sues FDA
A STAT Investigation Rachel Cohrs Zhang and Betsy Ladyzhets The NIH has poured $1 billion into long Covid research — with little to show for it
First Opinion Jordan Dworkin and Julian Elliott Strengthen science by funding living evidence synthesis
Pharmalot Ed Silverman STAT Plus: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug
Politics Sarah Owermohle and Rachel Cohrs Zhang STAT Plus: HHS chooses a location for ARPA-H — sort of
Politics Sarah Owermohle STAT Plus: Biden makes big demands for cancer research and new ARPA-H agency
Politics Jim Puzzanghera — Boston Globe STAT Plus: Hugh Auchincloss was Anthony Fauci’s longtime deputy. Now he’s taking his job as House Republicans probe the pandemic
Politics Rachel Cohrs Zhang HHS needs better oversight of research that alters pathogens, government watchdog says
First Opinion Bonnielin Swenor, Lisa I. Iezzoni, and Steven Barnett NIH advances landmark recommendations on disability inclusion and anti-ableism
Politics Rachel Cohrs Zhang A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
Special Report Jonathan Wosen STAT Plus: ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia
Pharmalot Ed Silverman STAT Plus: Lawmakers push NIH to disclose steps being taken to ensure clinical trial results are reported
Politics Sarah Owermohle STAT Plus: Biden appoints former government scientist as first leader of ARPA-H
In the Lab Theresa Gaffney Unprecedented! Incredible! Scientific grant applications are getting heavier on hype
D.C. Diagnosis Edward Chen A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
Politics Lev Facher STAT Plus: Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
Exclusive Lev Facher STAT Plus: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
Politics Lev Facher STAT Plus: Congress is closer than ever to formally authorizing ARPA-H. But the details aren’t as final as they seem
Politics Lev Facher STAT Plus: Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’